The Clinical Implications of Inhibition of the Inducible Form of Cyclo-Oxygenase
- 1 October 1996
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 15 (4) , 249-260
- https://doi.org/10.2165/00002018-199615040-00003
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cellsBiochemical Journal, 1995
- Transcriptional Regulation of Human Prostaglandin-endoperoxide Synthase-2 Gene by Lipopolysaccharide and Phorbol Ester in Vascular Endothelial CellsJournal of Biological Chemistry, 1995
- INDUCIBLE CYCLOOXYGENASE (COX-2): A SAFER THERAPEUTIC TARGET?Rheumatology, 1994
- Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes.1994
- Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.Journal of Clinical Investigation, 1994
- Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.Journal of Biological Chemistry, 1993
- Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.Journal of Biological Chemistry, 1992
- Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proceedings of the National Academy of Sciences, 1991
- Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damageThe American Journal of Medicine, 1989
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971